Japanese Medical Equipment Stock News

TSE:1736
TSE:1736Trade Distributors

3 Asian Dividend Stocks Yielding Up To 4.1%

As inflationary pressures and rising energy costs continue to shape global markets, investors are increasingly seeking stability in dividend stocks, particularly within the dynamic Asian markets. In such an environment, a good dividend stock is often characterized by its ability to provide consistent income streams while maintaining resilience against broader economic challenges.
TSE:7613
TSE:7613Electronic

High Growth Tech Stocks In Asia To Watch May 2026

As of May 2026, Asian markets are navigating a complex landscape influenced by global economic factors such as rising energy costs and inflationary pressures, similar to trends observed in other major economies. Despite these challenges, the region's tech sector continues to garner attention due to its potential for high growth, driven by robust domestic demand and technological advancements. In this environment, a promising tech stock typically demonstrates strong innovation capabilities and...
TSE:7167
TSE:7167Banks

Asian Stocks Trading Up To 35.3% Below Intrinsic Value Estimates

As global markets grapple with rising inflation and energy costs, Asian equities present intriguing opportunities for value investors. In this context, identifying stocks trading below their intrinsic value can be particularly appealing, offering potential upside in a market environment characterized by cautious sentiment and economic uncertainties.
TSE:3106
TSE:3106Luxury

Nanjing Develop Advanced Manufacturing Leads 3 Undiscovered Gems in Asia

As global markets grapple with rising inflation and geopolitical uncertainties, the Asian market continues to present unique opportunities for investors, particularly in the small-cap sector. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to navigating these challenges; Nanjing Develop Advanced Manufacturing is one such company leading a trio of undiscovered gems in Asia.
TSE:4553
TSE:4553Pharmaceuticals

Towa Pharmaceutical (TSE:4553) Valuation After Goodwill Impairment And FY2027 Recovery Outlook

Goodwill impairment hits guidance while dividend and FY2027 outlook steady Towa Pharmaceutical (TSE:4553) drew investor attention after announcing a large goodwill impairment at subsidiary Sunsho Pharmaceutical, which led to sharply reduced FY2026 profit guidance and raised questions about near term earnings quality. At the same time, the company kept its dividend plan unchanged and outlined expectations for higher sales and profit in FY2027. This combination puts the focus on how quickly...
TSE:6254
TSE:6254Machinery

Is Nomura Micro Science’s (TSE:6254) Higher Dividend Amid Weak Results a Signal of Quiet Confidence?

Nomura Micro Science has reported its fiscal 2026 results, revealing steep declines in sales and profits but also an increased annual dividend to ¥81 per share under its TTT-26 growth plan. By pairing higher shareholder payouts with a forecast for a sharp earnings recovery in fiscal 2027, management is signaling confidence in a demand rebound despite recent operational weakness. Next, we’ll examine how the dividend increase and confident fiscal 2027 guidance shape Nomura Micro Science’s...
TSE:9434
TSE:9434Wireless Telecom

How Investors Are Reacting To SoftBank (TSE:9434) Rising Full-Year Sales And Earnings Per Share

SoftBank Corp. has reported past full-year results for the 12 months to March 31, 2026, with sales of ¥7.04 trillion and net income of ¥550.76 billion, both higher than the prior year. The improvement in both basic and diluted earnings per share from continuing operations highlights how incremental profitability gains can compound meaningfully at SoftBank’s scale. Now we’ll examine how this uptick in full-year sales and net income may influence SoftBank’s existing investment narrative and...
TSE:4516
TSE:4516Pharmaceuticals

Should Lawsuit Over Deramiocel Deal and Gazyva Expansion Efforts Require Action From Nippon Shinyaku (TSE:4516) Investors?

Earlier this month, Capricor Therapeutics filed a lawsuit in New Jersey seeking to unwind its U.S. distribution deal with Nippon Shinyaku’s subsidiary over alleged pricing flaws and launch-preparation failures for Duchenne muscular dystrophy therapy Deramiocel, while Nippon Shinyaku also reported revenue growth, softer profit and an unchanged dividend for the year to March 2026. Ahead of its forecast for higher earnings in fiscal 2027, Nippon Shinyaku and Chugai applied in Japan to expand...
TSE:3360
TSE:3360Healthcare

Is Ship Healthcare (TSE:3360) Rebalancing Too Aggressively Between Growth And Shareholder Returns?

Earlier this week, Ship Healthcare Holdings reported its fiscal year 2026 results and held a board meeting to consider the distribution of surplus, outlining how it plans to return capital to shareholders. Alongside these disclosures, management highlighted key operational initiatives and a clearer shareholder return policy for fiscal year 2027, giving investors more detail on how future cash flows might be allocated between growth and returns. Next, we will examine how Ship Healthcare...
TSE:6501
TSE:6501Industrials

Assessing Hitachi (TSE:6501) Valuation After New AI Energy Parks Alliance With X LABS

Why this new energy parks alliance matters for Hitachi stock Hitachi (TSE:6501) has drawn fresh attention after agreeing with X LABS LLC to co develop gigawatt scale energy parks for AI focused data centers in North America, targeting behind the meter power needs. See our latest analysis for Hitachi. At a share price of ¥4,812, Hitachi has seen the share price fall 7.8% over the past month and 7.6% over the past quarter, even as the 1 year total shareholder return stands at 27.4% and the 5...
TSE:5706
TSE:5706Metals and Mining

Mitsui Kinzoku Rejects Activist Demands While Backing Sustainability Fund

Shareholders at Mitsui Kinzoku (TSE:5706) recently filed proposals calling for higher dividends, full executive pay disclosure, and a company name change linked to its environmental history. The Board rejected all shareholder proposals, keeping its current dividend policy, disclosure approach, and corporate name unchanged. At the same time, Mitsui Kinzoku agreed to join Emerald Technology Ventures’ Industrial Innovation Fund as a limited partner to access new industrial and sustainability...
TSE:6954
TSE:6954Machinery

Fanuc (TSE:6954) Is Up 9.5% After Embedding Google AI In Robots And Buying Back Shares - Has The Bull Case Changed?

Fanuc Corporation has completed a share buyback of 75,600 shares for ¥271.82 million under its April 23, 2025 program, while also announcing a partnership with Google to integrate Google Cloud’s Gemini Enterprise generative AI into its industrial robots. This collaboration aims to create “physical AI” systems that let Fanuc robots follow natural-language instructions and work together more flexibly on factory floors, potentially broadening how manufacturers use automation. We’ll now look at...
TSE:4151
TSE:4151Pharmaceuticals

Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance

If you are wondering whether Kyowa Kirin is attractively priced or not, the starting point is to understand what the current share price actually reflects about the business. Over the last week the stock is up 1.9%, although it is down 3.9% over the past month and down 5.7% year to date, while the 1 year return stands at 9.9% and the 5 year return shows a 22.0% decline. Recent coverage around Kyowa Kirin has focused on how investors interpret its long term prospects and the balance between...
TSE:4021
TSE:4021Chemicals

Nissan Chemical (TSE:4021) Margin Slippage To 17.1% Tests High‑Quality Earnings Narrative

Nissan Chemical (TSE:4021) FY 2026 earnings snapshot Nissan Chemical (TSE:4021) has put fresh numbers on the table for FY 2026, with third quarter revenue of ¥65,341 million and basic EPS of ¥90.67, set against trailing twelve month revenue of ¥271,968 million and EPS of ¥342.10. Over recent quarters the company has seen revenue move from ¥59,497 million in FY 2025 Q2 to ¥76,533 million in FY 2025 Q4 and then ¥69,871 million in FY 2026 Q1, while basic EPS has ranged from ¥64.95 to ¥102.20...
TSE:5076
TSE:5076Construction

Is INFRONEER Holdings' (TSE:5076) New Stock Grant Trust Reshaping Its Governance And Incentive Balance?

INFRONEER Holdings Inc. recently reported its fiscal year 2026 results, moved to change its dividend policy, and approved the disposal of 6.39 million treasury shares to fund new stock grant trusts for directors and employees. Alongside these capital and compensation moves, the group set up a Recurrence Prevention Committee after bribery-related misconduct at subsidiary MAEDA, underscoring an effort to reinforce compliance and rebuild public-sector trust. We will now examine how the new...
TSE:4307
TSE:4307IT

Nomura Research Institute Dividend Hike Tests Balance Between Income And Growth

Nomura Research Institute (TSE:4307) has announced a significant full year dividend increase. The company reaffirmed its commitment to stable shareholder returns, maintaining its payout policy. Management highlighted strong domestic business performance, while acknowledging recent impairment charges. For investors watching Nomura Research Institute at a share price of ¥4,332.0, the larger dividend stands out against a mixed return profile. The stock is down 11.1% over the past month and...
TSE:7184
TSE:7184Banks

Should First Bank Of Toyama’s New Buyback And Dividend Plans Reshape Capital Allocation Priorities (TSE:7184)?

On May 12, 2026, The First Bank Of Toyama, Ltd. announced a share repurchase program of up to 2,000,000 shares, or 3.18% of its issued share capital (excluding treasury stock), for ¥5,500,000,000, alongside plans to cancel treasury shares and consider a dividend increase approved at a board meeting held the same day. This combination of a buyback and potential dividend increase highlights the bank’s emphasis on flexible capital management amid changing business conditions, while operating...
TSE:6875
TSE:6875Semiconductor

Assessing MegaChips (TSE:6875) Valuation After Sharp 39.2% 30 Day Share Price Move

MegaChips (TSE:6875) has drawn attention after a recent share price move, with the stock up 4.0% in the past day and 39.2% over the past month, prompting fresh interest from investors. See our latest analysis for MegaChips. That 39.2% 30 day share price return sits on top of a 53.2% year to date share price return and a very large 5 year total shareholder return, suggesting momentum has been building over both shorter and longer horizons. If strong recent gains in semiconductors have your...
TSE:6366
TSE:6366Construction

Reassessing Chiyoda (TSE:6366) Valuation After Sharp Share Price Volatility And Mixed P/E And DCF Signals

Event context and recent price performance Chiyoda (TSE:6366) has recently drawn investor attention after a period of share price weakness, with the stock down about 18% over the past week and 30% over the past month. Over the past 3 months, the stock has fallen roughly 48%, while the year-to-date move is a more modest decline of about 3%. Despite this, the 1-year total return sits around 160%, which highlights how volatile the recent journey has been for investors. See our latest analysis...
TSE:6361
TSE:6361Machinery

Ebara (TSE:6361) Margin Softness Tests Bullish Earnings Growth Narrative

Q1 2026 earnings snapshot Ebara (TSE:6361) opened its Q1 2026 earnings season following Q4 2025 revenue of ¥294.7 billion and basic EPS of ¥69.78. Trailing twelve month EPS stood at ¥166.31 and revenue at ¥958.3 billion, framing the latest print against a recent run of profitability. The company’s revenue moved from ¥866.7 billion in the trailing twelve months to Q4 2024 to ¥958.3 billion in the trailing twelve months to Q4 2025, while basic EPS over the same period shifted from ¥154.62 to...
TSE:9432
TSE:9432Telecom

A Look At NTT (TSE:9432) Valuation After New Buyback Plan And Full Year 2026 Earnings

NTT (TSE:9432) has announced a share repurchase program of up to 1,400,000,000 shares, alongside full year 2026 results reporting sales of ¥14,409,121 million and net income of ¥1,037,032 million. See our latest analysis for NTT. At a share price of ¥151.8, NTT has seen relatively soft short term share price performance, with the share price return down 4.83% year to date, while the 5 year total shareholder return of 53.99% points to longer term compounding as investors react to earnings,...